ClinicalTrials.Veeva

Menu

EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING (PRIDE)

U

Universitair Ziekenhuis Brussel

Status

Not yet enrolling

Conditions

Pregnancy

Treatments

Device: AI algorithm

Study type

Interventional

Funder types

Other

Identifiers

NCT07187934
PRIDE_2025

Details and patient eligibility

About

This study aims to investigate whether embryo ranking by a fully automated AI tool (iDAScore) results in a similar transfer-to-pregnancy compared to manual embryo ranking by an embryologist. IVF patients who are planned for a freeze-all approach (where all usable embryos are frozen and transferred in later transfer cycles) will be allocated to either the control (ranking by embryologist) or intervention arm (ranking by iDAScore). The frozen embryos will be warmed and transferred one by one, according to their assigned rank. We want to see if the average number of embryo transfers that is needed to achieve a clinical pregnancy (transfer-to-pregnancy) is similar in both groups.

Full description

The study population consists of IVF/ICSI patients scheduled for a freeze-all policy on day 5. Inclusion takes place on the day prior to oocyte retrieval, based on predefined inclusion criteria. Embryo culture is performed in an EmbryoScope+ time-lapse incubator. On day 5 of embryo development, the embryologist evaluates the embryos using the Gardner criteria, assessing expansion stage, inner cell mass (ICM), and trophectoderm (TE). All embryos meeting our in-house cryopreservation criteria are vitrified. Embryos not yet meeting the criteria remain in culture and are re-evaluated on day 6. Once at least two blastocysts meet the cryopreservation criteria on day 5 and/or day 6, the patient is randomized in the control or study arm.

In the control group, the embryologist manually ranks all freezable embryos according to the assigned Gardner scores, applying a standard prioritization scheme: day of cryopreservation > expansion stage > TE score > ICM score.

If multiple embryos share the same Gardner score, the embryologist looks at the full morphokinetics to establish a final ranking. The order of warming for subsequent frozen embryo transfer (FET) cycles follows this ranking: the embryo ranked 1 is transferred first. If no clinical pregnancy results, the embryo ranked 2 is transferred in the next FET cycle, and so on.

In the study group, the iDA score is retrieved for each freezable embryo. Embryos are ranked solely based on their iDA score, with the highest score assigned rank 1, and so on. The order of warming for subsequent FET cycles is determined exclusively by this ranking. As in the embryologist group, the embryo ranked 1 is transferred first, followed by rank 2 in case of no clinical pregnancy, and so on.

+/- 10 days after embryo transfer, an hCG blood test is performed. In case of a positive result, the pregnancy is monitored until the 7-week ultrasound, at which the presence of fetal heartbeat confirms a clinical pregnancy. Patients are followed for clinical pregnancy outcomes of FETs performed up to one year after oocyte retrieval, or until the pregnancy outcome of the last available embryo is known.

In both the study and control arm, all procedures follow the standard of care. The only difference between the groups is the method of embryo ranking-and therefore the order in which embryos will be transferred.

Enrollment

1,325 estimated patients

Sex

Female

Ages

18 to 42 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients undergoing an ICSI/IVF treatment (with donor or own oocytes) that are planned for a 'freeze-all' strategy on day 5
  • all types of sperm samples (ejaculated or testicular, fresh or frozen, partner or donor origin)
  • Minimum 8 follicles (≥ 12 mm) on last follicular measurement before oocyte retrieval
  • 18 ≤ Age ≤ 42 years
  • 18 ≤ BMI ≤ 35 kg/m²
  • Maximum third IVF/ICSI cycle
  • Participants can be included only once in the trial

Exclusion criteria

  • Embassy patients
  • Use of frozen oocytes
  • In vitro maturation (IVM) cycles
  • Pre-implantation genetic Testing (PGT) cycles
  • Proven untreated intra-uterine pathologies (e.g. Asherman syndrome, adenomysosis)
  • Endometriosis stage 3/4

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

1,325 participants in 2 patient groups

Embryologist ranking
No Intervention group
Description:
Embryologist ranks the embryos according to their appearance
iDA ranking
Experimental group
Description:
AI tool ranks embryos based on fully automated analysis of time-lapse images
Treatment:
Device: AI algorithm

Trial contacts and locations

0

Loading...

Central trial contact

Tine Bosman, Msc; Elsie Nulens

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems